$HDSN
HUDSON TECHNOLOGIES INC /NY

2024 Q4 Form 10-Q Financial Statement

#000141057824001834 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $61.94M $76.50M
YoY Change -19.02% -14.53%
Cost Of Revenue $46.00M $45.92M
YoY Change 0.19% 1.44%
Gross Profit $15.94M $30.58M
YoY Change -47.87% -30.88%
Gross Profit Margin 25.74% 39.98%
Selling, General & Admin $8.059M $6.760M
YoY Change 19.22% -6.36%
% of Gross Profit 50.55% 22.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.620M $1.410M
YoY Change 14.89% 102.01%
% of Gross Profit 10.16% 4.61%
Operating Expenses $8.969M $7.458M
YoY Change 20.26% -5.8%
Operating Profit $6.973M $23.12M
YoY Change -69.84% -36.34%
Interest Expense $315.0K $4.358M
YoY Change -92.77% -284.27%
% of Operating Profit 4.52% 18.85%
Other Income/Expense, Net $2.250M -$4.358M
YoY Change -151.63%
Pretax Income $9.538M $18.76M
YoY Change -49.17% -44.74%
Income Tax $1.732M $5.182M
% Of Pretax Income 18.16% 27.62%
Net Earnings $7.806M $13.58M
YoY Change -42.53% -53.73%
Net Earnings / Revenue 12.6% 17.76%
Basic Earnings Per Share $0.17 $0.30
Diluted Earnings Per Share $0.17 $0.29
COMMON SHARES
Basic Shares Outstanding 45.20M 45.52M 45.40M
Diluted Shares Outstanding 47.14M 47.35M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.49M $3.800M
YoY Change 1386.5% -74.75%
Cash & Equivalents $56.49M $3.783M
Short-Term Investments
Other Short-Term Assets $11.31M $10.10M
YoY Change 11.96% -46.11%
Inventory $103.5M $139.2M
Prepaid Expenses
Receivables $28.55M $44.94M
Other Receivables $3.645M $0.00
Total Short-Term Assets $203.5M $198.1M
YoY Change 2.74% 2.84%
LONG-TERM ASSETS
Property, Plant & Equipment $25.29M $20.57M
YoY Change 22.96% -24.12%
Goodwill $62.40M $47.80M
YoY Change 30.54%
Intangibles $14.98M $15.47M
YoY Change -3.15%
Long-Term Investments
YoY Change
Other Assets $3.224M $2.418M
YoY Change 33.33% 217.32%
Total Long-Term Assets $105.9M $93.30M
YoY Change 13.52% -0.67%
TOTAL ASSETS
Total Short-Term Assets $203.5M $198.1M
Total Long-Term Assets $105.9M $93.30M
Total Assets $309.4M $291.4M
YoY Change 6.19% 1.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.06M $16.80M
YoY Change -34.17% 12.83%
Accrued Expenses $35.50M $35.30M
YoY Change 0.58% -11.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $5.000M
YoY Change -100.0%
Long-Term Debt Due $5.000M
YoY Change 17.65%
Total Short-Term Liabilities $46.56M $57.12M
YoY Change -18.48% -3.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.432M $5.200M
YoY Change 4.46% -15.83%
Total Long-Term Liabilities $5.432M $5.200M
YoY Change 4.46% -90.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.56M $57.12M
Total Long-Term Liabilities $5.432M $5.200M
Total Liabilities $55.53M $66.81M
YoY Change -16.88% -42.39%
SHAREHOLDERS EQUITY
Retained Earnings $137.2M $106.3M
YoY Change 29.07%
Common Stock $452.0K $455.0K
YoY Change -0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $253.9M $224.6M
YoY Change
Total Liabilities & Shareholders Equity $309.4M $291.4M
YoY Change 6.19% 1.69%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income $7.806M $13.58M
YoY Change -42.53% -53.73%
Depreciation, Depletion And Amortization $1.620M $1.410M
YoY Change 14.89% 102.01%
Cash From Operating Activities $30.27M $22.27M
YoY Change 35.91% -14.83%
INVESTING ACTIVITIES
Capital Expenditures $1.667M $1.380M
YoY Change 20.8% -254.19%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $19.00M -$1.380M
YoY Change -1477.03% 54.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.638M -28.53M
YoY Change -90.75% -7.63%
NET CHANGE
Cash From Operating Activities 30.27M 22.27M
Cash From Investing Activities 19.00M -1.380M
Cash From Financing Activities -2.638M -28.53M
Net Change In Cash 46.63M -7.640M
YoY Change -710.38% 35.63%
FREE CASH FLOW
Cash From Operating Activities $30.27M $22.27M
Capital Expenditures $1.667M $1.380M
Free Cash Flow $28.60M $20.89M
YoY Change 36.91% -22.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0000925528
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.hudsontech.com/20240930#AccruedLiabilitiesAndOtherLiabilitiesCurrent
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13412
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
dei City Area Code
CityAreaCode
845
dei Local Phone Number
LocalPhoneNumber
735-6000
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HDSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45198507
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56487000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12446000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28547000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25169000
CY2024Q3 us-gaap Inventory Net
InventoryNet
103523000
CY2023Q4 us-gaap Inventory Net
InventoryNet
154450000
CY2024Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
3645000
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
5438000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11308000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7492000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
203510000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
204995000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20075000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19375000
CY2024Q3 us-gaap Goodwill
Goodwill
62420000
CY2023Q4 us-gaap Goodwill
Goodwill
47803000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14982000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14771000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5217000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6591000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3224000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3137000
CY2024Q3 us-gaap Assets
Assets
309428000
CY2023Q4 us-gaap Assets
Assets
296672000
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
11060000
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
23399000
CY2024Q3 hdsn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
31595000
CY2023Q4 hdsn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
31537000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3908000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3615000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
46563000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58551000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3538000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4558000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3832000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4790000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1600000
CY2024Q3 us-gaap Liabilities
Liabilities
55533000
CY2023Q4 us-gaap Liabilities
Liabilities
67899000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45198507
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45198507
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45502380
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45502380
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
452000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
455000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116263000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118091000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
137180000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
110227000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
253895000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
228773000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
309428000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
296672000
CY2024Q3 us-gaap Revenues
Revenues
61943000
CY2023Q3 us-gaap Revenues
Revenues
76496000
us-gaap Revenues
Revenues
202475000
us-gaap Revenues
Revenues
244169000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
46001000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
45916000
us-gaap Cost Of Revenue
CostOfRevenue
142541000
us-gaap Cost Of Revenue
CostOfRevenue
146632000
CY2024Q3 us-gaap Gross Profit
GrossProfit
15942000
CY2023Q3 us-gaap Gross Profit
GrossProfit
30580000
us-gaap Gross Profit
GrossProfit
59934000
us-gaap Gross Profit
GrossProfit
97537000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8059000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6760000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
25019000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22010000
CY2024Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
910000
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
698000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2368000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2095000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
8969000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7458000
us-gaap Operating Expenses
OperatingExpenses
27387000
us-gaap Operating Expenses
OperatingExpenses
24105000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6973000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23122000
us-gaap Operating Income Loss
OperatingIncomeLoss
32547000
us-gaap Operating Income Loss
OperatingIncomeLoss
73432000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
315000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-4358000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-51000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8106000
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2250000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2250000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2565000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4358000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2199000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8106000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9538000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18764000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34746000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
65326000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1732000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5182000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7793000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17024000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
7806000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
13582000
us-gaap Net Income Loss
NetIncomeLoss
26953000
us-gaap Net Income Loss
NetIncomeLoss
48302000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45435458
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45404963
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45486263
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45348072
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47135443
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47345380
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47278638
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47319464
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
211450000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2023Q3 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
690000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
240000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
13582000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
224584000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
248668000
CY2024Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2635000
CY2024Q3 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
57000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
7806000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
253895000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
174875000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
693000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2061000
us-gaap Profit Loss
ProfitLoss
48302000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
224584000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
228773000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
2635000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
4000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
808000
us-gaap Profit Loss
ProfitLoss
26953000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
253895000
us-gaap Net Income Loss
NetIncomeLoss
26953000
us-gaap Net Income Loss
NetIncomeLoss
48302000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2274000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2213000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2368000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2095000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
441000
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
3811000
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-2195000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
14000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
800000
us-gaap Share Based Compensation
ShareBasedCompensation
808000
us-gaap Share Based Compensation
ShareBasedCompensation
2061000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
171000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
669000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3427000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1020000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4280000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
733000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24863000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-52189000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8341000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6732000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
684000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-6000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
1000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1794000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4212000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11229000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3283000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71103000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43518000
hdsn Payments To Acquire Business Net Of Escrow Holdbacks And Inventory Adjustments
PaymentsToAcquireBusinessNetOfEscrowHoldbacksAndInventoryAdjustments
20670000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3752000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2215000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24422000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2215000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
39000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2636000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-4000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-693000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
5000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
47161000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2640000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-42815000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
44041000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1512000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12446000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5295000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56487000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3783000
us-gaap Interest Paid Net
InterestPaidNet
529000
us-gaap Interest Paid Net
InterestPaidNet
4232000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7042000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16955000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for credit losses. In accordance with the “expected credit loss” model, the carrying amount of accounts receivable is reduced by a valuation allowance that reflects the Company’s best estimate of the amounts that it does not expect to collect. In addition to reviewing delinquent accounts receivable, the Company considers many factors in estimating its reserve, including types of customers and their credit worthiness, experience and historical data adjusted for current conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The carrying value of the Company’s accounts receivable is reduced by the established allowance for credit losses. The allowance for credit losses includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the nine month period ended September 30, 2024 there was one customer accounting for greater than 10% of the Company’s revenues and at September 30, 2024 there were $4.9 million of accounts receivable from this customer. For the nine month period ended September 30, 2023 there was one customer accounting for greater than 10% of the Company’s revenues and at September 30, 2023 there were $19.7 million of accounts receivable from this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q3 hdsn Cylinder Deposit Value
CylinderDepositValue
19300000
CY2023Q4 hdsn Cylinder Deposit Value
CylinderDepositValue
17200000
CY2016Q3 hdsn Contract Term
ContractTerm
P5Y
CY2016Q3 hdsn Renewal Term
RenewalTerm
P5Y
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
61943000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
76496000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
202475000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
244169000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
7806000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
13582000
us-gaap Net Income Loss
NetIncomeLoss
26953000
us-gaap Net Income Loss
NetIncomeLoss
48302000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45435458
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45404963
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45486263
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45348072
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1699985
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1940417
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1792375
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1971392
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47135443
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47345380
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47278638
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47319464
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
692092
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7444
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
59963
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7444
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties, and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for credit losses, inventory reserves, goodwill and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for credit losses based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrofluorocarbon (“HFC”) and hydrofluroolefin (“HFO”) refrigerants and reclaimable, primarily hydrochlorofluorocarbons (“HCFC”), HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of September 30, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reclassification</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p>
CY2024Q3 us-gaap Inventory Gross
InventoryGross
112538000
CY2023Q4 us-gaap Inventory Gross
InventoryGross
159654000
CY2024Q3 us-gaap Inventory Adjustments
InventoryAdjustments
9015000
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
5204000
CY2024Q3 us-gaap Inventory Net
InventoryNet
103523000
CY2023Q4 us-gaap Inventory Net
InventoryNet
154450000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
61862000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59084000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41787000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39709000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20075000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19375000
us-gaap Depreciation
Depreciation
2300000
us-gaap Depreciation
Depreciation
2200000
CY2024Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1155000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1668000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1500000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1043000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
656000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
823000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6845000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1546000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5299000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1467000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1898000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3832000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4790000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5299000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6688000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y11M1D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0836
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0827
us-gaap Operating Lease Payments
OperatingLeasePayments
1408000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
1782000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
28000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1020000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q3 us-gaap Goodwill
Goodwill
62400000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
35577000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20595000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14982000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18226000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14771000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2100000
CY2024Q3 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
7187790
CY2024Q3 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2705055
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y6M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.50
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
14200000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
26900000
CY2024Q3 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
0.0
CY2023Q4 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Nonvested.
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonvested.
800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2300000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10728000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12256000
CY2024Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
19328000
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
17225000
CY2024Q3 hdsn Lease Obligations Current
LeaseObligationsCurrent
1471000
CY2023Q4 hdsn Lease Obligations Current
LeaseObligationsCurrent
1893000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
68000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
163000
CY2024Q3 hdsn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
31595000
CY2023Q4 hdsn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
31537000
CY2024Q3 hdsn Earn Out Liability
EarnOutLiability
1600000
CY2024Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000
CY2024Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
326028
CY2024Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2629168
CY2024Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
8.06
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-001834-index-headers.html Edgar Link pending
0001410578-24-001834-index.html Edgar Link pending
0001410578-24-001834.txt Edgar Link pending
0001410578-24-001834-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hdsn-20240930.xsd Edgar Link pending
hdsn-20240930x10q.htm Edgar Link pending
hdsn-20240930xex31d1.htm Edgar Link pending
hdsn-20240930xex31d2.htm Edgar Link pending
hdsn-20240930xex32d1.htm Edgar Link pending
hdsn-20240930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hdsn-20240930_cal.xml Edgar Link unprocessable
hdsn-20240930_def.xml Edgar Link unprocessable
hdsn-20240930_lab.xml Edgar Link unprocessable
hdsn-20240930_pre.xml Edgar Link unprocessable
hdsn-20240930x10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending